Rising Demand For Invasive Medical Treatments Is Expected To Boost The Growth Of Syringes Market By 10% CAGR During The Forecast Period; States Fact.MR

As Per Region, U.S. Is Projected To Be The Most Lucrative Market Owing To High Geriatric Population And Vast Covid-19 Vaccination Drives


South Korea, Seoul, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: The global syringes market was valued at USD 14.2 billion in 2020, and it is expected to reach USD 37 billion by 2031, projected to witness a CAGR of 10% during the forecast period 2021-2031.

Syringe based drug administration is expected to be the most preferred treatment alternative, owing to the comparatively rapid action time over other oral drugs. Due to this perception, syringes continue to remain dominant in the healthcare industry. Moreover, the market is expected to expand 2.6x.

Surge in demand for invasive medical treatments and rise in adoption of
Self-administration of drugs, medical device manufacturers are putting emphasis on providing key surgical instruments such as syringes. 

Besides this, medical professionals are also focusing on the advent of all-purpose syringes that can reduce the imprint of dumping plastic syringes on a large scale.

For more insights into the Market, Request Brochure of this Report

https://www.factmr.com/connectus/sample?flag=B&rep_id=59

Moreover, growing reliance on biological drugs to offer faster outcomes has increased the sales of drug injection, which has led to higher traction to the global syringes market. Besides this, owing to their highly complexity, biologics offer syringes for administration, spurring numerous product launches in the global market.

Besides this, the COVID-19 pandemic has led to a boost in the growth of syringes market owing to its widespread application in vaccinating people at a global level. Moreover, In 2020, As per Biomedical Advanced Research and Development Authority (BARDA). 650 to 850 million syringes and needles will be required in the US. In addition to this, UNICEF had planned to buy 1 billion syringes by the end of 2021 for COVID-19 vaccination efforts in various countries.

Key Takeaways:

  • The U.S is expected to be the most dominant market across the North American regions owing to surge in geriatric population and Covid-19 vaccination drives. Also, as of 2020, around US $ 2.5 Billion worth of syringes were sold in the US. Moreover, the U.S. government announced a public-private initiative, with the initiative to facilitate the production of more than 500 million in 2021.
  • Asia is expected to offer lucrative growth opportunities and is projected to show the highest growth rate, especially during the Covid-19 pandemic.
  • As per the end user, hospitals are expected to emerge as the dominant end user of syringes. Moreover, it is expected that over 66% of revenues will be generated from hospitals.

Growth Drivers:

  • Regions such as Asia exhibit lucrative opportunities for syringes manufacturers. It is expected to contribute to the growth of the market especially amidst the Covid-19 pandemic. Moreover, as vaccination drives have been initiated, the demand for syringes is expected to rise exponentially
  • Rise in reliance on biologic drugs to facilitate better outcomes has boosted the sales of drug injections. This is expected to drive the growth of syringes market during the forecast period.
  • Rise in global incidences of various chronic and infectious ailments is expected to boost the growth of injectable drugs market.

For Comprehensive Insights Ask An Analyst Here

https://www.factmr.com/connectus/sample?flag=AE&rep_id=59

Competitive Landscape:

The global syringes market is competitive in nature. High capital investment for entering the market has offered barriers for new market players. Moreover, leading market players are focusing their efforts on developing innovative products to establish their market position in the global market.

  • In January 2021, Aurobindo Pharma Limited had received final approval from the US Food & Drug Administration (USFDA) to market Naloxone HCl Injection Prefilled Syringe 2 mg/2 mL.

Key Companies Profiled by Fact.MR

  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Gerresheimer AG
  • Hindustan Syringes & Medical Devices Limited
  • Terumo Corporation
  • Nipro Corporation
  • Schott AG
  • Medtronic Plc.
  • Smith’s Group Plc.
  • Codan Medizinische Geräte GmbH & Co Kg.

More Valuable Insights on Syringes Market

Segmentation of Syringes Market

  • Product Type
    • General Syringes
    • Specialized Syringes
    • Conventional Syringes
    • Safety Syringes
    • Retractable Syringes
    • Other Syringes
  • Usability
    • Disposable Syringes
    • Reusable Syringes
  • Material
    • Glass Syringes
    • Polymer Syringes
  • End User
    • Syringes for Hospitals
    • Syringes for Blood Collection Centers
    • Syringes for Diabetic Care Centers
    • Syringes for Veterinary Care Centers
    • Syringes for Other End Users

Get Customization on this Report for Specific Research Solutions

https://www.factmr.com/connectus/sample?flag=RC&rep_id=59

Explore Fact.MR’s Coverage on the Healthcare Domain

Blood Transfusion Diagnostics Market - The demand for blood transfusions has experienced an upsurge since the past several years. This is attributed to a large number of patients undergoing surgical procedures for various chronic diseases, such as aplastic anemia, sickle cell anemia and leukemia. This has prompted key players to focus on research & development for advanced instruments, assays and kits in blood banks and hospitals.

Genetic Testing Services Market - Genetic Testing Services Market is expected to expand at a robust CAGR of 7.6% during the forecast period, 2020-2025. The global market is anticipated to reach a value of US$ 64.1 Billion by the end of 2025.

Fluid Management Market - The demand for intravenous administration of fluids and medicines to chronically ill and dehydrated patients who don’t respond to oral therapy is anticipated to leverage the infusion therapy market. Projections indicate a modest CAGR of 5.3% during the forecast period.

High-flow Nasal Cannula Market - According to the Global Burden of Disease Study, 2013, around 300 million people suffered from COPD during that year. This is attributed to growing addiction for smoking, deteriorating air quality and rising pollution across the globe. The prevalence of respiratory disorders will further boost market prospects.

Orthopedic Devices Market - The global orthopedic devices market is poised to grow moderately at a CAGR of 4.0% during the forecast period (2020-2026). This growth trajectory is attributed to the prevalence of a wide range of orthopedic disorders such as osteoarthritis, rheumatoid arthritis, fibromyalgia and juvenile arthritis. This is attributed to the prevalence of an aging population, lifestyle changes and obesity.

Immunoglobulins Market - The neurology segment held the maximum market share throughout the historical period, comprising almost 2/5th of the global immunoglobulins market. This trend is expected to continue across the forecast period. The immunology segment accounted for the 2nd largest share in the global immunoglobulins market and is poised to capture over 35% market share throughout the forecast period.

High Performance Liquid Chromatography (HPLC) Market - HPLC test is a sophisticated and expensive analytical technique, widely used in food processing as well as clinical diagnosis of diseases or disorders. It is used for drug analysis, separation of molecules, and environmental control in the pharmaceutical industry.

Medical Holography Market - The medical holography market was valued at US$ 447.8 Million in 2019 and is projected to reach a value pool US$ 3.5 Billion by 2026, registering a stellar CAGR of 34.0% throughout the forecast period. This is in response to increasing demand for medical holography imaging.

Opthalmic Drugs Market - The global ophthalmic drugs market shall gain moderate traction during the forecast period (2020-2025), registering a CAGR of 4.2%. There is an increase in incidences of eye-related diseases, particularly in developing nations, over the past several years.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Follow Us: LinkedIn | Twitter